Hedge Fund Database

ORBIMED ADVISORS LLC

Adviser information for ORBIMED ADVISORS LLC last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 112
Investment Advisory/Research 83
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 5

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 31 $18.2B
Non-Discretionary 0 $0
Total 31 $18.2B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 31 $18.2B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 61

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-61046
SEC ERA File Number 801-61046
SEC CIK Numbers 1055951
SEC CRD Numbers 118608
Legal Entity Identifier 57G4FX4JA0RP0CHYJ782

Principal Office

601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9AM TO 5PM
Tel: 212-739-6400, Fax: 212-739-6444

Websites

www.linkedin.com www.orbimed.com www.twitter.com www.facebook.com

Chief Compliance Officer

DOUGLAS COON
CHIEF COMPLIANCE OFFICER
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY
United States
Tel: 212-739-6400
Fax: 212-739-6444
(Full email address available in API data)

Regulatory Contact

ALEXANDER M. COOPER
GENERAL COUNSEL
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY
United States
Tel: 212-739-6400
Fax: 212-739-6444
(Full email address available in API data)

Industry Affiliates

ORBIMED ADVISORS INDIA PRIVATE LIMITED Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ASIA GP II, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ASIA GP III, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ASIA GP IV, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ASIA GP V, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ASIA GP, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP IV LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP IX LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP V LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP VI LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP VII LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL GP VIII LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED CAPITAL LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED GENESIS GP LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ISRAEL GP II, L.P. Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ISRAEL PARTNERS LIMITED Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED NEW HORIZONS GP LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ROF II LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ROF III LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ORBIMED ROF IV LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
ORBIMED ASIA PARTNERS II, L.P. FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",213134000,10000000,415,2,2,",42,"N $M $M 0
ORBIMED ASIA PARTNERS III, L.P. FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",1796966000,10000000,117,2,41,",52,"N $M $M 0
ORBIMED ASIA PARTNERS IV, L.P. FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",933030000,10000000,132,4,22,",51,"N $M $M 0
ORBIMED ASIA PARTNERS V, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",732659000,1000000,95,4,14,",56,"N $M $M 0
ORBIMED ASIA PARTNERS, L.P. FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",88509000,10000000,145,5,0,",38,"N $M $M 3
ORBIMED GENESIS MASTER FUND, L.P. Hedge Fund $428.6M $1.0M 91
ORBIMED ISRAEL PARTNERS II, L.P. FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",352984000,5000000,116,3,22,",16,"N $M $M 0
ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",54442000,5000000,76,2,9,",58,"N $M $M 0
ORBIMED NEW HORIZONS MASTER FUND, L.P. Hedge Fund $76.6M $1.0M 84
ORBIMED PARTNERS MASTER FUND LIMITED Hedge Fund $775.3M $1.0M 195
ORBIMED PARTNERS SPV, LTD. Hedge Fund $88.5M $0.1M 59
ORBIMED PRIVATE INVESTMENTS IV, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",100746000,10000000,158,3,40,",26,"N $M $M 0
ORBIMED PRIVATE INVESTMENTS IX, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",1925036000,1000000,292,3,19,",32,"N $M $M 0
ORBIMED PRIVATE INVESTMENTS V, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND". $344.6M $10.0M 462
ORBIMED PRIVATE INVESTMENTS VI, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",1002608000,10000000,140,3,30,",25,"N $M $M 0
ORBIMED PRIVATE INVESTMENTS VII, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",1385799000,10000000,145,3,31,",28,"N $M $M 0
ORBIMED PRIVATE INVESTMENTS VIII, LP FUND MEETS THE DEFINITION OF BOTH "VENTURE CAPITAL FUND" AND "HEDGE FUND",1705852000,10000000,186,5,22,",27,"N $M $M 0
ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP Private Equity Fund $967.7M $0.5M 113
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV OFFSHORE, LP Private Equity Fund $589.4M $0.5M 135
ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP Private Equity Fund $1,531.6M $1.0M 405
ORBIMED ROYALTY OPPORTUNITIES II, LP Hedge Fund $210.3M $0.8M 272
ROYALTY OPPORTUNITIES S.�R.L. Hedge Fund $85.4M $10.0M 194

Control Persons

Name Type Entity Title Since Ownership
BORHO, SVEN, HEINZ Individual – MEMBER 01/1998 25-50%
GORDON, CARL, LEE Individual – MEMBER 01/1998 25-50%
NEILD, WILLIAM, CARTER Individual – MEMBER 01/2007 10-25%
HSU, GEOFFREY, CHE-CHANG Individual – MEMBER 01/2010 5-10%
COOPER, ALEXANDER, MATTHEW Individual – GENERAL COUNSEL 07/2010 < 5%
COON, DOUGLAS, W. Individual – CHIEF COMPLIANCE OFFICER 02/2016 < 5%
STEVENS, CHARLES, SCOTLAND Individual – MEMBER 04/2019 < 5%
BLOCK III, SAM Individual – CHIEF FINANCIAL OFFICER 05/2019 < 5%
BONITA, DAVID, PAUL Individual – MEMBER 01/2020 < 5%
Rizzo, Matthew, Scott Individual – MEMBER 01/2022 < 5%
Thompson, Peter, Armstrong Individual – MEMBER 01/2022 < 5%

No. Employees, Historic

2001000201920202021202220232024202591 on 5/23/201991 on 5/24/201991 on 2/5/202091 on 2/5/202089 on 3/30/202089 on 5/22/202089 on 8/21/202089 on 11/25/202099 on 3/30/202199 on 1/7/202298 on 3/23/202298 on 8/3/202298 on 11/14/202298 on 2/28/2023106 on 3/29/2023112 on 3/27/2024

RAUM, Historic

30B15B0201920202021202220232024202514900000000 on 5/23/201914900000000 on 5/24/201914900000000 on 2/5/202014900000000 on 2/5/202014910510000 on 3/30/202014910510000 on 5/22/202014910510000 on 8/21/202014910510000 on 11/25/202021447005000 on 3/30/202121447005000 on 1/7/202217321130000 on 3/23/202217321130000 on 8/3/202217321130000 on 11/14/202217321130000 on 2/28/202318277550000 on 3/29/202318211070000 on 3/27/2024

No. Clients, Historic

40200201920202021202220232024202523 on 5/23/201923 on 5/24/201923 on 2/5/202023 on 2/5/202026 on 3/30/202026 on 5/22/202026 on 8/21/202026 on 11/25/202032 on 3/30/202132 on 1/7/202232 on 3/23/202232 on 8/3/202232 on 11/14/202232 on 2/28/202333 on 3/29/202331 on 3/27/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ABCELLERA BIOLOGICS INC COM 12M 4M –
ACELYRIN INC COM 18M 4M –
ADC THERAPEUTICS SA SHS 14M 4M –
ADICET BIO INC COM 14M 11M –
ALNYLAM PHARMACEUTICALS INC COM 61M 250K –
ALX ONCOLOGY HLDGS INC COM 11M 2M –
AMGEN INC COM 42M 135K –
AMICUS THERAPEUTICS INC COM 6M 570K –
APELLIS PHARMACEUTICALS INC COM 50M 1M –
APOGEE THERAPEUTICS INC COM 15M 379K –
APOLLOMICS INC CL A SHS 2M 9M –
ARGENX SE SPONSORED ADR 90M 209K –
ARRIVENT BIOPHARMA INC COM 56M 3M –
ARS PHARMACEUTICALS INC COM 79M 9M –
AVIDITY BIOSCIENCES INC COM 29M 706K –
BIOGEN INC COM 209M 901K –
BIOMARIN PHARMACEUTICAL INC COM 2M 26K –
BIOMX INC COM 5M 14M –
BOSTON SCIENTIFIC CORP COM 252M 3M –
C4 THERAPEUTICS INC COM STK 7M 2M –
CHEMOMAB THERAPEUTICS LTD SPONSORED ADS 2M 2M –
COMPASS THERAPEUTICS INC COM 22M 22M –
CORVUS PHARMACEUTICALS INC COM 13M 7M –
CRINETICS PHARMACEUTICALS IN COM 57M 1M –
CULLINAN THERAPEUTICS INC COM 20M 1M –
CYTOKINETICS INC COM NEW 44M 813K –
DEXCOM INC COM 33M 290K –
DISC MEDICINE INC COM 80M 2M –
DYNAVAX TECHNOLOGIES CORP COM NEW 1M 114K –
DYNE THERAPEUTICS INC COM 25M 708K –
EDGEWISE THERAPEUTICS INC COM 271M 15M –
ELEVANCE HEALTH INC COM 91M 168K –
ELEVATION ONCOLOGY INC COM 3M 941K –
ELI LILLY & CO COM 306M 338K –
ENLIVEN THERAPEUTICS INC COM 186M 8M –
EVOLENT HEALTH INC CL A 50M 3M –
EXACT SCIENCES CORP COM 28M 672K –
FATE THERAPEUTICS INC COM 4M 1M –
GERON CORP COM 3M 600K –
GERON CORP COM 38M 9M –
HERON THERAPEUTICS INC COM 23M 7M –
ICON PLC SHS 55M 174K –
IKENA ONCOLOGY INC COM 6M 4M –
IKENA ONCOLOGY INC NONVOTING 11M 6M –
IMMATICS N.V SHS 23M 2M –
INSPIREMD INC COM 5M 2M –
INTEGER HLDGS CORP COM 40M 349K –
INTUITIVE SURGICAL INC COM NEW 219M 493K –
INVIVYD INC COM 3M 2M –
IONIS PHARMACEUTICALS INC COM 113M 2M –
JANUX THERAPEUTICS INC COM 125M 3M –
KEROS THERAPEUTICS INC COM 58M 1M –
KEZAR LIFE SCIENCES INC COM 1M 2M –
KRYSTAL BIOTECH INC COM 6M 30K –
LAKESHORE BIOPHARMA CO LTD ORDINARY SHARES 910K 1M –
LEXICON PHARMACEUTICALS INC COM NEW 10M 6M –
LYELL IMMUNOPHARMA INC COM 9M 6M –
MERCK & CO INC COM 163M 1M –
MERUS N V COM 3M 50K –
MERUS N V COM 9M 156K –
MILESTONE PHARMACEUTICALS IN COM 3M 2M –
MINERALYS THERAPEUTICS INC COM 24M 2M –
MORPHIC HLDG INC COM 21M 613K –
NATERA INC COM 74M 688K –
NEUMORA THERAPEUTICS INC. COM 15M 2M –
NEUROCRINE BIOSCIENCES INC COM 62M 448K –
NEUROPACE INC COM 26M 3M –
NEXTCURE INC COM 2M 1M –
NKARTA INC COM 5M 800K –
ORIC PHARMACEUTICALS INC COM 2M 287K –
PASSAGE BIO INC COM 8M 10M –
PERSPECTIVE THERAPEUTICS INC COM NEW 5M 493K –
PFIZER INC COM 7M 250K –
PMV PHARMACEUTICALS INC COM 10M 6M –
PRELUDE THERAPEUTICS INC COM 42M 11M –
PRELUDE THERAPEUTICS INC NONVOTING 22M 6M –
PROGYNY INC COM 7M 260K –
Q32 BIO INC COM 40M 2M –
REGENERON PHARMACEUTICALS COM 24M 23K –
REPARE THERAPEUTICS INC COM 11M 3M –
RHYTHM PHARMACEUTICALS INC COM 29M 705K –
SAREPTA THERAPEUTICS INC COM 102M 646K –
SAREPTA THERAPEUTICS INC COM 8M 50K –
SCHOLAR ROCK HLDG CORP COM 9M 1M –
SCPHARMACEUTICALS INC COM 24M 6M –
SI-BONE INC COM 3M 250K –
SI-BONE INC COM 42M 3M –
SINGULAR GENOMICS SYSTEMS IN COM NEW 152K 18K –
SINOVAC BIOTECH LTD SHS 340M 3M –
SOLVENTUM CORP COM SHS 11M 200K –
SPRINGWORKS THERAPEUTICS INC COM 64M 2M –
STRUCTURE THERAPEUTICS INC SPONSORED ADS 5M 125K –
STRYKER CORPORATION COM 92M 269K –
SYNDAX PHARMACEUTICALS INC COM 40M 2M –
TELA BIO INC COM 12M 2M –
TENET HEALTHCARE CORP COM NEW 156M 1M –
TERNS PHARMACEUTICALS INC COM 52M 8M –
TG THERAPEUTICS INC COM 2M 133K –
THERMO FISHER SCIENTIFIC INC COM 73M 132K –
THIRD HARMONIC BIO INC COM 75M 6M –
TRAWS PHARMA INC COM NEW 467K 1M –
TURNSTONE BIOLOGICS CORP COM 8M 3M –
TYRA BIOSCIENCES INC COM 12M 769K –
UNITEDHEALTH GROUP INC COM 57M 112K –
VAXCYTE INC COM 60M 796K –
VERA THERAPEUTICS INC CL A 24M 676K –
VERASTEM INC COM NEW 5M 2M –
VERONA PHARMA PLC SPONSORED ADS 41M 3M –
VERTEX PHARMACEUTICALS INC COM 71M 151K –
VIGIL NEUROSCIENCE INC COM 2M 449K –
VIR BIOTECHNOLOGY INC COM 21M 2M –
X4 PHARMACEUTICALS INC COM 4M 7M –
XENON PHARMACEUTICALS INC COM 34M 862K –
XERIS BIOPHARMA HOLDINGS INC COM 181K 80K –
XTANT MED HLDGS INC COM NEW 46M 73M –